Dr. C. Vivek Lal’s second education

The decision to become an entrepreneur arrived after Dr. C. Vivek Lal already had a career worth keeping. There was a professional reputation, an established research life, and a family whose future could hardly be treated as an experiment. He remembers asking his wife whether he should take the next step. Her answer was brief: “go do it.” Some business plans receive more elaborate endorsements. Few receive one that matters as much.

Lal tells that story with gratitude. His wife was also a physician and entrepreneur, with a demanding schedule of her own. They had twins. The choice belonged inside a household before it could belong inside a pitch deck. His account gives entrepreneurship a recognizably adult setting: ambition has company, and the people accompanying it deserve a say.

Today, he is the founder and CEO of resbiotic, the founder of Biostack Ventures, and a professor at the University of Alabama at Birmingham. His working life joins research, company building, and investment. The interesting part is how much learning came after the formal qualifications. He had spent years becoming an expert. Then he volunteered for a field in which expertise would need considerable assistance.

02An island childhood, a longer itinerary

Lal grew up in India’s Andaman Islands. He describes parents who valued hard work and achievement. His mother hoped he would become a doctor; he has said that medicine was not originally his own plan. He pursued it anyway, moving to the United States for advanced training. His father encouraged initiative, including the useful instruction to begin before every practical uncertainty had been settled.

The education took him through several institutions. He attended Government Medical College in Nagpur, completed residency at the University of South Alabama in Mobile, and undertook fellowship training at UT Southwestern Medical Center in Dallas. UAB’s faculty biography also lists doctoral training in genetics, genomics, and bioinformatics. The itinerary matters because it gives the later entrepreneur a history of entering unfamiliar rooms and doing the work required to stay.

He subsequently completed an executive program at MIT. More education, certainly, but with a different destination. His conference biography places that program after his clinical and research fellowships. By then, his interests were extending into the practical business of moving ideas beyond a university. There is something pleasing about an accomplished academic remaining willing to be a student. A string of qualifications can become a comfortable place to sit. Lal kept adding another chair to the classroom.

03The company built beside his wife

Urgent Care for Children supplied an early operating education. Lal and his wife co-founded the business, and he credits the experience with teaching him business skills. Establishing and growing a company gave him a practical introduction to raising money and building an organization. The apprenticeship happened alongside someone who understood both his professional world and the consequences of changing it.

That venture later reached a different kind of milestone. On June 30, 2025, Zarminali Pediatrics announced its acquisition of Urgent Care for Children. Allury Lal took on the role of Alabama state medical director at Zarminali. The announcement gives the couple’s business story a concrete later chapter: an enterprise they helped create became part of another organization.

In his public response to the acquisition, Lal thanked the team and welcomed the buyer. He also singled out Allury’s next role. It was an account of a shared undertaking, with named people continuing the work. An acquisition makes a convenient punctuation mark in a founder’s biography. Here, the people on either side of that punctuation remained visible.

There is a reason to linger over this company even in a profile of resbiotic’s founder. His business experience preceded the brand now associated with his name. The lessons had already come with employees, partners, and responsibilities. When he moved into another venture, he could bring that experience with him. The scientist was learning what an operator has to know.

04Birmingham supplied the room to build

Resbiotic emerged from Lal’s work at UAB. In April 2021, the young business announced $3 million in seed funding from a syndicate led by Timberline Holdings. At that point, Lal’s title was founder and chief scientific officer. The company was preparing for a first commercial product in early 2022 and planned to be based at Birmingham’s Innovation Depot.

The early leadership list is revealing. Amit Gaggar joined as chief medical officer. Andrew O’Connor, an engineer with a Harvard MBA, was named chief operating officer. Scott Bush took responsibility for strategy, while Birmingham entrepreneur Sanjay Singh served as a business adviser. Those appointments put distinct kinds of experience around the founder. No single set of credentials was expected to do every job.

The university setting was part of the story, too. Lal remained connected to academic research while companies formed around his work. His conference biography identifies him as founder and executive chairman of Alveolus Bio as well as CEO of resbiotic. The resulting career has several institutional homes, each with its own work to organize. An impressive biography is easy to print; coordinating the organizations behind it is the less decorative activity.

“Entrepreneurship is the toughest thing I have done.”

Dr. C. Vivek Lal

05The shelf had questions of its own

When resbiotic’s first product launched in January 2022, Lal expected the underlying work to make its importance apparent. He later described discovering how much explanation an unfamiliar category required. During the first six months, the team questioned the investment of money and effort. They persisted with education, concentrating first on an audience comfortable assessing research.

That is a useful episode because Lal allows his initial expectation to remain in the account. He thought customers would understand quickly. They needed more help. A scientist can spend years becoming fluent in an idea and then meet a customer who is hearing it for the first time. The distance between those two people becomes a business problem.

The early operating team makes sense in that light. Strategy, operations, and advice were already part of the organization. A company needs ways to explain itself, reach people, and deliver what it sells. Those tasks continue after a launch announcement has done its brief turn in the spotlight. The next customer still arrives without having read the founder’s papers.

06A trophy with a long guest list

Recognition followed. Resbiotic received UAB’s Start-Up of the Year award in 2022. In October 2023, the Bill L. Harbert Institute for Innovation and Entrepreneurship gave Lal its Award for Excellence in Entrepreneurship. The event brought together people and organizations from the university, Birmingham, and Alabama. His work had become part of a local account of company creation.

His response on LinkedIn was to redirect attention toward colleagues. He wrote that “the award truly belongs” to the members of Alveolus Bio and resbiotic, then named a long list of people. Among them were Gaggar, O’Connor, Singh, and Allury. The thank-you was specific enough to restore a little of the organizational detail that an individual award usually removes.

In 2024, UAB included him in its campus chapter of the National Academy of Inventors. That chapter recognizes university innovators who hold US patents. Membership added another form of recognition to a career already spanning academic and commercial work. Each institution was acknowledging a different part of the same busy professional life.

By July 2026, resbiotic had won the NutraIngredients USA Start-Up Award in Chicago. Again, Lal emphasized the people around the company, including collaborators, investors, retailers, and customers. The award photograph captures a more sociable moment than a formal faculty portrait: a smile, an occasion, and a trophy that required rather more than one person’s effort.

07What $14.5 million was meant to do

In September 2025, resbiotic announced $14.5 million in total funding, including a recently completed $8 million Series A supported by Sororibus Capital and Biostack Ventures. The distinction matters: the Series A was included in the total. The announcement attached the money to specific plans for product expansion, retail and ecommerce distribution, and a business supplying ingredients and formulations to other companies.

For Lal, that meant building several routes to market. Selling directly online, working with retailers, and serving other businesses ask different things of an organization. They also create different relationships. The founder who once needed to explain a new category was now preparing to work through a wider set of commercial channels.

Biostack Ventures gives that interest in building companies a broader home. Its platform describes work from identifying opportunities and validating ventures through operating support, commercialization, and investment. Lal is its founder. The portfolio includes resbiotic and Alveolus Bio, while Urgent Care for Children is marked as exited. The sequence is familiar by this point: investigate an opportunity, assemble people, build something, and decide how it should grow.

08Texas, with a return address

A later milestone brought the story back to Dallas. On July 31, 2026, resbiotic announced a launch at H-E-B stores across Texas, identifying itself as headquartered in Dallas. The city was already part of Lal’s earlier life through his training at UT Southwestern. Now it appeared in the business’s address and in a retail expansion across the state.

The announcement presented the launch as a homecoming. It is a modestly satisfying turn in a career that has moved through islands, Indian classrooms, Mobile, Dallas, and Birmingham. Places in a professional biography tend to become a list of institutions. Sometimes they return as somewhere a person has reason to care about reaching.

After the 2026 award, Lal said, “We’re still at the beginning.” It is a familiar sentiment among founders, but the chronology gives it some substance here. A company he co-founded had been acquired. Another had raised capital and reached additional retail shelves. Biostack’s platform extended his role into supporting further ventures. The beginning had acquired several chapters.

His mother’s ambition helped send him toward a profession. His father’s encouragement favored taking initiative. His wife’s support made a later change possible. Colleagues helped give that change an organization. Lal’s second education has required all of them. The degrees remain in the biography. The continuing lesson is in the work he chooses to undertake next.